Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.12 USD | -9.41% | -8.31% | +56.48% |
09/05 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.48% | 454M | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.09% | 22.25B | |
-13.14% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Citigroup Upgrades Larimar Therapeutics to Buy From Neutral, Price Target is $4.50